EUVIMEDEUVIMED entdecken
Open Access

Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells

Ziad Joha iD, Oğuzhan Kalkan iD, Fatih Yulak iD, Mustafa Ergül, Mustafa Asım Gedikli iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Ziad Joha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey. Hauptthemen laut MEDLINE: Cisplatin, Esomeprazole, Stomach Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The authors extend their sincere gratitude to the Sivas Cumhuriyet University, School of Medicine, CUTFAM Research Center, Sivas, Turkey, for the provision of….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proton pump inhibitors (PPIs), including esomeprazole, impact the acidic tumor microenvironment, potentially influencing cancer cell behavior. By examining the combined effects of esomeprazole and cisplatin on SNU‐1 gastric carcinoma cells, this study sought to elucidate the mechanisms through which esomeprazole enhances cisplatin's cytotoxicity, potentially allowing for effective treatment with reduced cisplatin dosages. SNU‐1 cells were treated with varying doses of esomeprazole and cisplatin, alone and in combination. Cell viability was assessed using the XTT assay. Oxidative stress (TAS/TOS), apoptosis (Annexin V, cleaved PARP), mitochondrial membrane potential, and DNA damage (8‐oxo‐dG, γH2AX, ATM) were evaluated using flow cytometry and ELISA. Statistical significance was determined by ANOVA. Esomeprazole alone showed no significant effect on SNU‐1 cell viability, oxidative stress (TAS/TOS), apoptosis, mitochondrial membrane potential, or DNA damage. Cisplatin, however, significantly reduced cell viability (IC50 = 3.024 µg/mL), increased oxidative stress (decreased TAS, increased TOS), diminished apoptosis (increased Annexin V binding and cleaved PARP levels), disrupted mitochondrial membrane potential, and caused significant DNA damage (increased H2AX and ATM phosphorylation, and elevated 8‐oxo‐dG) ( p < 0.001). Notably, the combination of esomeprazole and cisplatin synergistically enhanced cisplatin's effects. The combination resulted in a significantly greater reduction in cell viability (CI < 1), a further increase in oxidative stress, a higher level of apoptosis, amplified mitochondrial depolarization, and potentiated DNA damage compared to cisplatin alone ( p < 0.001). Esomeprazole potentiates cisplatin‐induced cytotoxicity in SNU‐1 gastric cancer cells by enhancing oxidative stress, apoptosis, mitochondrial dysfunction, and DNA damage. This suggests a potential therapeutic strategy to improve cisplatin efficacy and overcome resistance in gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinEsomeprazoleStomach NeoplasmsAntineoplastic AgentsHumansCell Line, TumorApoptosisOxidative StressDrug SynergismDNA DamageCell SurvivalMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

DNA damageapoptosiscisplatincombinationesomeprazolemitochondrial membrane potential

Substanzen

CisplatinEsomeprazoleAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey.
  • Department of Emergency, Pursaklar State Hospital, Ankara, Turkey.
  • Department of Physiology, School of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.
  • Department of Biochemistry, Sivas Cumhuriyet University School of Pharmacy, Sivas, Turkey.
  • Department of Internal Medicine, School of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.

ORCID-Profile: Ziad Joha, Oğuzhan Kalkan, Fatih Yulak, Mustafa Asım Gedikli

Förderung

  • The authors extend their sincere gratitude to the Sivas Cumhuriyet University, School of Medicine, CUTFAM Research Center, Sivas, Turkey, for the provision of…

Zitieren

APA

Joha, Z., Kalkan, O., Yulak, F., Ergül, M., & Gedikli, M. A. (2025). Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70441

Vancouver

Joha Z, Kalkan O, Yulak F, Ergül M, Gedikli MA. Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70441

BibTeX
@article{Joha2025,
  author = {Joha, Ziad and Kalkan, Oğuzhan and Yulak, Fatih and Ergül, Mustafa and Gedikli, Mustafa Asım},
  title = {Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70441}
}
Kostenlos starten →